2.85
2.06%
-0.06
After Hours:
2.87
0.02
+0.70%
Nautilus Biotechnology Inc stock is traded at $2.85, with a volume of 42,505.
It is down -2.06% in the last 24 hours and up +9.62% over the past month.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
See More
Previous Close:
$2.91
Open:
$2.88
24h Volume:
42,505
Relative Volume:
0.60
Market Cap:
$356.17M
Revenue:
-
Net Income/Loss:
$-63.68M
P/E Ratio:
-6.0638
EPS:
-0.47
Net Cash Flow:
$-54.15M
1W Performance:
+2.33%
1M Performance:
+9.62%
6M Performance:
-3.06%
1Y Performance:
-9.81%
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Name
Nautilus Biotechnology Inc
Sector
Industry
Phone
206-333-2001
Address
2701 EASTLAKE AVE EAST, SEATTLE
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-06-22 | Initiated | Morgan Stanley | Equal-Weight |
Nov-02-21 | Initiated | Cowen | Outperform |
Aug-04-21 | Initiated | Goldman | Neutral |
Jul-13-21 | Initiated | Jefferies | Buy |
Nautilus Biotechnology Inc Stock (NAUT) Latest News
Clearline Capital LP Lowers Stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Insider Selling: Nautilus Biotechnology, Inc. (NASDAQ:NAUT) VP Sells 47,031 Shares of Stock - Defense World
Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com
Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com Canada
Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com India
Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com UK
Nautilus Biotechnology senior VP sells shares worth over $99k - Investing.com India
Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com Canada
Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com Australia
Nautilus Biotechnology senior VP sells shares worth over $99k - Investing.com
Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com UK
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer | Daily - Daily Guardian Canada
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - GlobeNewswire
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - StockTitan
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - Yahoo Finance
Nautilus Biotechnology, Inc.'s (NASDAQ:NAUT) Top Key Executive Parag Mallick is the most upbeat insider, and their holdings increased by 11% last week - Simply Wall St
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Down 0.8% - MarketBeat
Nautilus Biotechnology Insider Ups Holding During Year - Yahoo Finance
XPeng Inc. (NYSE:XPEV) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Vanguard Group Inc. Acquires 29,604 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - StockTitan
Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - Yahoo Finance
Nautilus Biotechnology (NASDAQ:NAUT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2024 Earnings Call Transcript - Insider Monkey
Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript - Seeking Alpha
NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q2 2024 - InvestorPlace
Nautilus Down on Releasing Q2 Numbers - Baystreet.ca
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - GlobeNewswire
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - StockTitan
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - Yahoo Finance
We're Not Very Worried About Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate - Simply Wall St
Hybrid Software Group PLC Publishes 2024 Interim Report - Yahoo Finance UK
Nautilus Biotechnology (NAUT) Set to Announce Earnings on Tuesday - Defense World
Nautilus Biotechnology (NAUT) to Release Earnings on Tuesday - MarketBeat
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Down 2.5% - MarketBeat
Short Interest in Graco Inc. (NYSE:GGG) Rises By 6.2% - Defense World
Zacks Research Research Analysts Lower Earnings Estimates for Embraer S.A. (NYSE:ERJ) - Defense World
Nautilus Biotechnology (NASDAQ:NAUT) Trading Down 2.5% - Defense World
Analysts Issue Forecasts for IDEAYA Biosciences, Inc.’s Q2 2024 Earnings (NASDAQ:IDYA) - Defense World
AI-Enabled Biotech - Madrona Venture Group
Revolutionizing Proteomics: Sujal Patel, Co-Founder & CEO of Nautilus, on Drug Development - Audacy
Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 - GlobeNewswire
Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024 - Yahoo Finance
With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future - Yahoo Finance
Owning 33% in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) means that insiders are heavily invested in the ... - Yahoo New Zealand News
Nautilus Biotechnology (NASDAQ:NAUT) Coverage Initiated by Analysts at Guggenheim - Defense World
Analyst sets Nautilus Biotech shares at Buy on innovative technology By Investing.com - Investing.com Australia
Analyst sets Nautilus Biotech shares at Buy on innovative technology By Investing.com - Investing.com India
Amerant Bank appoints new Palm Beach Market President By Investing.com - Investing.com
Guggenheim Initiates Coverage on Nautilus Biotechnology (NASDAQ:NAUT) - MarketBeat
Guggenheim Initiates Coverage of Nautilus Biotechnology (NAUT) with Buy Recommendation - Nasdaq
Nautilus Biotechnology Inc Stock (NAUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):